California's AB 824 law has important implications for branded and generics companies involved in settlement agreements. AB ...

Improvements in diagnostics for the early detection of Alzheimer's disease have the potential to transform patient care and ...

They say the mark of intelligence is making the complex simple. By that standard, navigating early commercialization in the pharmaceutical industry is one of the toughest challenges, especially for ...

On this week's Business of Biotech, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna Rose Welch, editorial and community director at ...